Table 5.
Assessed Outcomes, Overall and Stratified by ST131 and H30R Status, Among the 236 Patients With Documented Manifestations of Infection
| Outcome | No. of Isolates (Column %) |
P Value, ST131 vs Non-ST131 | No. of Isolates (Column %) |
P Value, H30R vs Non-H30R | |||
|---|---|---|---|---|---|---|---|
| Overall (n = 236) | ST131 (n = 39) | Non-ST131 (n = 197) | H30R (n = 31) | Non-H30R (n = 205) | |||
| Clinical recurrence | 9 (3.8) | 2 (5.1) | 7 (3.6) | .65 | 2 (6.5) | 7 (3.4) | .61 |
| Microbiological recurrence | 3 (1.3) | 0 | 3 (1.5) | 1 | 0 (0) | 3 (1.5) | 1 |
| Clostridium difficile infection | 2 (0.8) | 0 | 2 (1.0) | 1 | 0 (0) | 2 (1.0) | 1 |
| Mortality, overall | 8 (3.4) | 0 | 8 (4.1) | .36 | 0 (0) | 8 (3.9) | .39 |
| In-hospital mortality | 8 (3.4) | 0 | 8 (4.1) | .36 | 0 (0) | 8 (3.9) | .39 |
| ICU admission | 15 (6.3) | 2 (5.1) | 13 (6.6) | 1 | 2 (6.5) | 13 (6.3) | 1 |
| Escalation in level of care | 14 (5.9) | 1 (2.6) | 13 (6.6) | .48 | 1 (3.2) | 13 (6.3) | .70 |
| Use of advanced imaginga | 56 (23.7) | 8 (20.5) | 48 (24.4) | .68 | 6 (19.4) | 50 (24.4) | .65 |
| Any of above | 77 (32.6) | 11 (28.2) | 66 (33.5) | .58 | 9 (29.0) | 66 (32.2) | .84 |
Abbreviations: H30R, ST131 subclone H30R; ICU, intensive care unit; ST131, sequence type 131.
a Computerized tomography, magnetic resonance imaging, or ultrasonography.